Recently, nanovesicles that overcome the disadvantages of naturalexosomes have been generated artificially from cells.
2
The lower dose of ASC-derived artificial nanovesicles had similar regenerative capacity compared with a higher dose of ASCs and ASC-derived naturalexosomes.
3
The proliferation rate of lung epithelial cells was increased in cells treated with ASC-derived artificial nanovesicles compared with cells treated with ASC-derived naturalexosomes.